Comparative benefits and harms of second-generation antidepressants for treating major depressive disorder: an updated meta-analysis

G Gartlehner, RA Hansen, LC Morgan… - Annals of internal …, 2011 - acpjournals.org
Background: Second-generation antidepressants dominate the management of major
depressive disorder (MDD), but evidence on the comparative benefits and harms of these …

Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application

MJ Millan - Pharmacology & therapeutics, 2006 - Elsevier
Major depression is a debilitating and recurrent disorder with a substantial lifetime risk and a
high social cost. Depressed patients generally display co-morbid symptoms, and depression …

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2008 British Association for Psychopharmacology guidelines

A Cleare, CM Pariante, AH Young… - Journal of …, 2015 - journals.sagepub.com
A revision of the 2008 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken in order to …

Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines

IM Anderson, IN Ferrier, RC Baldwin… - Journal of …, 2008 - journals.sagepub.com
A revision of the 2000 British Association for Psychopharmacology evidence-based
guidelines for treating depressive disorders with antidepressants was undertaken to …

Sexual dysfunction, depression, and the impact of antidepressants

SH Kennedy, S Rizvi - Journal of clinical psychopharmacology, 2009 - journals.lww.com
Sexual dysfunction is a common symptom of depression. Although decreased libido is most
often reported, difficulties with arousal, resulting in vaginal dryness in women and erectile …

Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute …

JP Boulenger, H Loft, CK Olsen - International clinical …, 2014 - journals.lww.com
This study assessed the efficacy, tolerability and safety of vortioxetine versus placebo in
adults with recurrent major depressive disorder. This double-blind, randomized, placebo …

Comparing the efficacy of benzodiazepines and serotonergic anti-depressants for adults with generalized anxiety disorder: a meta-analytic review

AF Gomez, AL Barthel, SG Hofmann - Expert opinion on …, 2018 - Taylor & Francis
Introduction: Generalized anxiety disorder (GAD) is a common form of anxiety disorder.
Selective serotonin reuptake inhibitors (SSRIs), serotonin and norepinephrine reuptake …

The impact of mental illness on sexual dysfunction

Z Zemishlany, A Weizman - Sexual dysfunction, 2008 - karger.com
Sexual dysfunction is prevalent among psychiatric patients and may be related to both the
psychopathology and the pharmacotherapy. The negative symptoms of schizophrenia limit …

Comparative benefits and harms of second-generation antidepressants: background paper for the American College of Physicians

G Gartlehner, BN Gaynes, RA Hansen… - Annals of internal …, 2008 - acpjournals.org
Background: Second-generation antidepressants dominate the management of major
depressive disorder, dysthymia, and subsyndromal depression. Evidence on the …

Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta …

U Reichenpfader, G Gartlehner, LC Morgan… - Drug safety, 2014 - Springer
Background Sexual dysfunction (SD) is prevalent in patients with major depressive disorder
(MDD) and is also associated with second-generation antidepressants (SGADs) that are …